Successful sirolimus therapy of an aplastic anemia patient with chronic kidney disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Successful sirolimus therapy of an aplastic anemia patient with chronic kidney disease

Published:2020-06-05 Issue:23 Volume:99 Page:e20669
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Niu Haiyue,Qi Weiwei,Wang Yihao,Xing Limin,Fu Rong,Shao Zonghong,Wang Huaquan

Funder

The National Natural Science Foundation of China

Tianjin Provincial Key Research and Development Program

Application Bases and Advanced Technology Research Program of Tianjin

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference13 articles.

1. Current concepts in the pathophysiology and treatment of aplastic anemia;Young;Blood,2006

2. How I treat acquired aplastic anemia;Bacigalupo;Blood,2017

3. Effect of rapamycin on the cyclosporin A resistant CD28-mediated costimulatory pathway;Ghosh;Blood,2002

4. Selection of patients for bone marrow transplantation in severe aplastic anemia;Camitta;Blood,1975

5. KDIGO clinical practice guideline for Lipid management in CKD: summary of recommendation statements and clinical approach to the patient;Wanner;Kidney Int,2014

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnosis and management of acquired aplastic anemia in childhood. Guidelines from the Marrow Failure Study Group of the Pediatric Haemato-Oncology Italian Association (AIEOP);Blood Cells, Molecules, and Diseases;2024-09

2. Treatment of newly diagnosed severe aplastic anemia in children: Evidence‐based recommendations;Pediatric Blood & Cancer;2024-05-16

3. A gold-based immunochromatographic strip for the detection of sirolimus in human whole blood;The Analyst;2022

4. Case Report: Sirolimus Alleviates Persistent Cytopenia After CD19 CAR-T-Cell Therapy;Frontiers in Oncology;2021-12-23

5. A Multidrug Approach to Modulate the Mitochondrial Metabolism Impairment and Relative Oxidative Stress in Fanconi Anemia Complementation Group A;Metabolites;2021-12-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3